BMO Capital Sticks to Their Buy Rating for Pfizer (PFE)

BMO Capital Sticks to Their Buy Rating for Pfizer (PFE)  The Globe and Mail

Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.